Cellular mechanisms of IL-17-induced blood-brain barrier disruption
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Recently T-helper 17 (Th17) cells were demonstrated to disrupt the blood-brain barrier (BBB) by the action of IL-17A. The aim of the present study was to examine the mechanisms that underlie IL-17A-induced BBB breakdown. Barrier integrity was analyzed in the murine brain endothelial cell line bEnd.3 by measuring the electrical resistance values using electrical call impedance sensing technology. Furthermore, in-cell Western blots, fluorescence imaging, and monocyte adhesion and transendothelial migration assays were performed. Experimental autoimmune encephalomyelitis (EAE) was induced in C57BL/6 mice. IL-17A induced NADPH oxidase- or xanthine oxidase-dependent reactive oxygen species (ROS) production. The resulting oxidative stress activated the endothelial contractile machinery, which was accompanied by a down-regulation of the tight junction molecule occludin. Blocking either ROS formation or myosin light chain phosphorylation or applying IL-17A-neutralizing antibodies prevented IL-17A-induced BBB disruption. Treatment of mice with EAE using ML-7, an inhibitor of the myosin light chain kinase, resulted in less BBB disruption at the spinal cord and less infiltration of lymphocytes via the BBB and subsequently reduced the clinical characteristics of EAE. These observations indicate that IL-17A accounts for a crucial step in the development of EAE by impairing the integrity of the BBB, involving augmented production of ROS.-Huppert, J., Closhen, D., Croxford, A., White, R., K…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IL-17 impairs blood–brain barrier integrity, allowing for more immune cells to cross into the CNS [127,128].”
From The Role of Cortisol in Chronic Stress, Neurodegenerative Diseases, and Psychological Disorders (2023) · cites this paper as [127]
In the citing paper
“In turn, IL-17 further impairs BBB integrity, thus allowing more immune cells and cytokines to gain easy access to the CNS [65, 66].”
From Chronic stress-induced depression requires the recruitment of peripheral Th17 cells into the brain (2022) · cites this paper as [65]
Citations
Cites
Noseworthy, J. H., Lucchinetti, C., Rodriguez, M., & Weinshenker, B. G. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009283431307 · Cited by 2,899
Kebir, H., Kreymborg, K., Ifergan, I., Dodelet-Devillers, A., Cayrol, R., Bernard, M., Giuliani, F., Arbour, N., Becher, B., & Prat, A. (2007) · Nature Medicine · doi:10.1038/nm1651 · Cited by 1,759 · cited 4×
“Recently, it was shown that both IL-17A and IL-22 can disturb BBB integrity, but the exact mechanism by which this occurs is not clear (5).”
BackgroundInfluentialSelf-citationMultiple Sclerosis — The Plaque and Its Pathogenesis
Frohman, E. M., Racke, M. K., & Raine, C. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052130 · Cited by 1,740 · cited 1×
“Multiple sclerosis (MS) is an autoimmune inflammatory disease of the CNS that is characterized by sclerotic lesions found throughout the brain white matter (1).”
BackgroundIL-23 is essential for T cell–mediated colitis and promotes inflammation via IL-17 and IL-6
Yen, D., Cheung, J., Scheerens, H., Poulet, F., McClanahan, T., Mckenzie, B., Kleinschek, M. A., Owyang, A., Mattson, J., Blumenschein, W., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci21404 · Cited by 1,542
IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis
Komiyama, Y., Nakae, S., Matsuki, T., Nambu, A., Ishigame, H., Kakuta, S., Sudo, K., & Iwakura, Y. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.566 · Cited by 1,536
TH-17 cells in the circle of immunity and autoimmunity
Bettelli, E., Oukka, M., & Kuchroo, V. K. (2007) · Nature Immunology · doi:10.1038/ni0407-345 · Cited by 1,517 · cited 1×
“A correlative link between IL-17A expression and the development of EAE has been well documented, as Th17 cells are abundant in the CNS of mice before and during the peak of the disease ( 35 ).”
BackgroundTzartos, J. S., Friese, M. A., Craner, M. J., Palace, J., Newcombe, J., Esiri, M. M., & Fugger, L. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.070690 · Cited by 1,187 · cited 1×
“Th17 cells, which produce the cytokines IL-17A, IL-17F, and IL-22, were shown to infiltrate the CNS in patients with MS and in mice with EAE (23, 24).”
BackgroundAn essential role for free radicals and derived species in signal transduction
Lander, H. M. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.2.9039953 · Cited by 902 · cited 1×
“We and others have demonstrated previously that ROS-induced activation of the endothelial contractile machinery leads to BBB disruption (14, 16, 26, 27, 36).”
BackgroundGarcia, J. G. N., Liu, F., Verin, A. D., Birukova, A., Dechert, M. A., Gerthoffer, W. T., Bamberg, J. R., & English, D. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12450 · Cited by 886 · cited 1×
“The endothelial contractile machinery is strongly regulated by the phosphorylation of myosin light chains (MLCs) ( 28 ).”
BackgroundRouvier, E., Luciani, M. F., Mattéi, M. G., Denizot, F., & Golstein, P. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.12.5445 · Cited by 775
Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis
Matusevicius, D., Kivisäkk, P., He, B., Kostulas, N., Özenci, V, Fredrikson, S., & Link, H. (1999) · Multiple Sclerosis Journal · doi:10.1177/135245859900500206 · Cited by 751 · cited 1×
“MS (7) and also with many other autoimmune inflam-”
BackgroundBlood-brain barrier disruption in multiple sclerosis
Minagar, A., & Alexander, J. S. (2003) · Multiple Sclerosis Journal · doi:10.1191/1352458503ms965oa · Cited by 638 · cited 1×
“Th17 cells, which produce the cytokines IL-17A, IL-17F, and IL-22, were shown to infiltrate the CNS in patients with MS and in mice with EAE (23, 24).”
BackgroundWong, C. K., Ho, C. Y., Li, E., & Lam, C. (2000) · Lupus · doi:10.1191/096120300678828703 · Cited by 472 · cited 1×
“High expression of IL-17A is associated with MS (7) and also with many other autoimmune inflammatory diseases, including rheumatoid arthritis (8), inflammatory bowel disease (9), and systemic lupus erythematosus ( 10 ).”
BackgroundCayrol, R., Wosik, K., Berard, J. L., Dodelet-Devillers, A., Ifergan, I., Kebir, H., Haqqani, A. S., Kreymborg, K., Krug, S., Moumdjian, R., et al. (2008) · Nature Immunology · doi:10.1038/ni1551 · Cited by 444 · cited 2×
“After the monocytes adhere, they transmigrate through the endothelial cells into the subendothelial space, reaching the neuronal and glial cells, and cause the characteristic tissue destruction (e.g., demyelination) (32, 33 ).”
BackgroundSelf-citationTherapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis
Hofstetter, H. H., Ibrahim, S. M., Koczan, D., Kruse, N., Weishaupt, A., Toyka, K. V., & Gold, R. (2005) · Cellular Immunology · doi:10.1016/j.cellimm.2005.11.002 · Cited by 423 · cited 1×
“without IL-17A, IL-17F, or both cytokines (22, 40, 41).”
BackgroundLubberts, E., Joosten, L. A. B., Oppers, B., van den Bersselaar, L., Coenen-de Roo, C. J. J., Kolls, J. K., Schwarzenberger, P., van de Loo, F. A. J., & van den Berg, W. B. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.2.1004 · Cited by 401 · cited 1×
“matory diseases, including rheumatoid arthritis (8),”
IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice
Haak, S., Croxford, A. L., Kreymborg, K., Heppner, F. L., Pouly, S., Becher, B., & Waisman, A. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35997 · Cited by 399 · cited 2×
“without IL-17A, IL-17F, or both cytokines (22, 40, 41).”
BackgroundSelf-citationSchreibelt, G., Kooij, G., Reijerkerk, A., van Doorn, R., Gringhuis, S. I., van der Pol, S., Weksler, B. B., Romero, I. A., Couraud, P., Piontek, J., et al. (2007) · The FASEB Journal · doi:10.1096/fj.07-8329com · Cited by 347 · cited 2×
“We and others have demonstrated previously that ROS-induced activation of the endothelial contractile machinery leads to BBB disruption (14, 16, 26, 27, 36).”
Backgroundvan Horssen, J., Schreibelt, G., Drexhage, J., Hazes, T., Dijkstra, C. D., van der Valk, P., & de Vries, H. E. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.09.023 · Cited by 318 · cited 1×
“heme oxygenase 1, and peroxiredoxin-1 in active demyelinating MS lesions and the EAE model is clearly associated with a loss of BBB integrity (17, 18).”
BackgroundPulmonary Endothelial Cell Barrier Enhancement by Sphingosine 1-Phosphate
Dudek, S. M., Jacobson, J. R., Chiang, E. T., Birukov, K. G., Wang, P., Zhan, X., & Garcia, J. G. N. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313969200 · Cited by 301 · cited 1×
“The MLC phosphorylation state is controlled by MLCK kinase and MLC phosphatase ( 29 , 30).”
BackgroundBrown, R. C., Morris, A. P., & O'Neil, R. G. (2007) · Brain Research · doi:10.1016/j.brainres.2006.10.083 · Cited by 291 · cited 1×
“3; American Type Culture Collection (ATCC), Manassas, VA, USA] were used as a BBB model as described previously (19).”
MethodFloris, S., Blezer, E. L. A., Schreibelt, G., Döpp, E., van der Pol, S. M. A., Schadee‐Eestermans, I. L., Nicolay, K., Dijkstra, C. D., & de Vries, H. E. (2004) · Brain · doi:10.1093/brain/awh068 · Cited by 272
Steffen, B. J., Butcher, E. C., & Engelhardt, B. (1994) · PubMed · Cited by 214
Vaccination against IL‐17 suppresses autoimmune arthritis and encephalomyelitis
Röhn, T. A., Jennings, G. T., Hernandez, M., Grest, P., Beck, M., Zou, Y., Kopf, M., & Bachmann, M. F. (2006) · European Journal of Immunology · doi:10.1002/eji.200636658 · Cited by 195
Haorah, J., Heilman, D., Knipe, B., Chrastil, J., Leibhart, J., Ghorpade, A., Miller, D. W., & Persidsky, Y. (2005) · Alcoholism: Clinical & Experimental Research · doi:10.1097/01.alc.0000166944.79914.0a · Cited by 169 · cited 1×
“Similar observations were made after induction of hypoxia (14) or treatment of HBECs with alcohol ( 37 ), which both resulted in NAD(P)H oxidase-dependent ROS generation that was responsible for MLC phosphorylation.”
MethodSchreibelt, G., Musters, R. J. P., Reijerkerk, A., de Groot, L. R., van der Pol, S. M. A., Hendrikx, E. M. L., Döpp, E. D., Dijkstra, C. D., Drukarch, B., & de Vries, H. E. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.4.2630 · Cited by 167 · cited 5×
“We and others have demonstrated previously that ROS-induced activation of the endothelial contractile machinery leads to BBB disruption (14, 16, 26, 27, 36).”
BackgroundResultInfluentialReijerkerk, A., Kooij, G., van der Pol, S. M. A., Khazen, S., Dijkstra, C. D., & de Vries, H. E. (2006) · The FASEB Journal · doi:10.1096/fj.06-6099fje · Cited by 156 · cited 2×
“In addition, monocytes have been demonstrated to traverse the BBB by a matrix metalloproteinase-dependent degradation of occludin (34).”
BackgroundResultDevelopment of an anti‐IL‐17A auto‐vaccine that prevents experimental auto‐immune encephalomyelitis
Uyttenhove, C., & Snick, J. V. (2006) · European Journal of Immunology · doi:10.1002/eji.200636662 · Cited by 154
Mechanisms of C-Reactive Protein-Induced Blood–Brain Barrier Disruption
Kuhlmann, C. R. W., Librizzi, L., Closhen, D., Pflanzner, T., Lessmann, V., Pietrzik, C. U., de Curtis, M., & Luhmann, H. J. (2009) · Stroke · doi:10.1161/strokeaha.108.535930 · Cited by 138 · cited 1×
“To examine whether astrocytic factors influence TEER values, the culture medium was supplemented with astrocyte-conditioned medium, as described in more detail previously (21).”
MethodSelf-citationMigration of Multiple Sclerosis Lymphocytes Through Brain Endothelium
Prat, A., Biernacki, K., Lavoie, J.-F., Poirier, J., Duquette, P., & Antel, J. P. (2002) · Archives of Neurology · doi:10.1001/archneur.59.3.391 · Cited by 121 · cited 1×
“a prerequisite for the formation of MS lesions (3).”
BackgroundAfonso, P. V., Ozden, S., Prévost, M., Schmitt, C., Seilhean, D., Weksler, B. B., Couraud, P., Gessain, A., Romero, I. A., & Ceccaldi, P. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.4.2576 · Cited by 107 · cited 3×
“Previous observations indicated that BBB disruption involves the activation of the endothelial contractile machinery, elevation of intracellular calcium levels, and the generation of ROS (14, 16, 25, 26).”
BackgroundResultHaorah, J., Schall, K. A., Ramirez, S. H., & Persidsky, Y. (2007) · Glia · doi:10.1002/glia.20596 · Cited by 106 · cited 5×
“We and others have demonstrated previously that ROS-induced activation of the endothelial contractile machinery leads to BBB disruption (14, 16, 26, 27, 36).”
BackgroundResultInfluentialLagrange, P., Romero, I. A., Minn, A., & Revest, P. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00112-4 · Cited by 91 · cited 1×
“Oxidative stress is known for its deleterious effects, which can cause enhanced permeability of the BBB (14, 15 ).”
BackgroundWong, D., Prameya, R., & Dorovini-Zis, K. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.12.003 · Cited by 88 · cited 1×
“tion of BECs with proinflammatory cytokines (4).”
Koch, M. W., Ramsaransing, G. S. M., Arutjunyan, A. V., Stepanov, M., Teelken, A. W., Heersema, D. J., & Keyser, J. D. (2005) · Journal of Neurology · doi:10.1007/s00415-005-0037-3 · Cited by 86
Inhibition of the myosin light chain kinase prevents hypoxia‐induced blood–brain barrier disruption
Kuhlmann, C. R. W., Tamaki, R., Gamerdinger, M., Leßmann, V., Behl, C., Kempski, O. S., & Luhmann, H. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04506.x · Cited by 84 · cited 8×
“ML-7 was shown to be active in vivo and to be devoid of toxic effects ( 14 ).”
BackgroundMethodResultInfluentialSelf-citationVolk, T. J., Hensel, M., Schuster, H., & Kox, W. J. (2000) · Molecular and Cellular Biochemistry · doi:10.1023/a:1007059616914 · Cited by 68 · cited 1×
“chemoattractant protein-1 (39), we hypothesize that a”
Benton, R. L., Maddie, M. A., Worth, C. A., Mahoney, E. T., Hagg, T., & Whitternore, S. R. (2008) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2008.76 · Cited by 42 · cited 1×
“Tissue was homogenized as described previously (20) and costained with CyQuant DNA stain.”
MethodProtective effects of peroxiredoxin-1 at the injured blood–brain barrier
Schreibelt, G., van Horssen, J., Haseloff, R. F., Reijerkerk, A., van der Pol, S. M. A., Nieuwenhuizen, O. F. M., Krause, E., Blasig, I. E., Dijkstra, C. D., Ronken, E., et al. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.03.024 · Cited by 40 · cited 1×
“heme oxygenase 1, and peroxiredoxin-1 in active demyelinating MS lesions and the EAE model is clearly associated with a loss of BBB integrity (17, 18).”
BackgroundArias, W. M., Mezquita, C., & Mezquita, J. (2000) · Journal of Cellular Biochemistry · doi:10.1002/1097-4644(2000)79:1<113::aid-jcb110>3.0.co;2-9 · Cited by 13 · cited 1×
“The MLC phosphorylation state is controlled by MLCK kinase and MLC phosphatase (29, 30 ).”
BackgroundDiagnostic criteria for primary progressive mutiple sclerosis: a position paper.
(2000) · Pure Amsterdam UMC · doi:10.1002/1531-8249(200006)47:6 · Cited by 2
Research works printed but not linked: 1
- 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q · DOI
Cited by
Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis
Brinkmann, V., Billich, A., Baumruker, T., Heining, P., Schmouder, R., Francis, G., Aradhye, S., & Burtin, P. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3248 · Cited by 1,273
“This prevents the local generation of terminally differentiated effector T cells and T EM cells in the CNS, and it abrogates T cell-mediated astrogliosis and disruption of the blood–brain barrier (BBB”
BackgroundMultiple Sclerosis: Mechanisms and Immunotherapy
Baecher-Allan, C., Kaskow, B. J., & Weiner, H. L. (2018) · Neuron · doi:10.1016/j.neuron.2018.01.021 · Cited by 938
Functional morphology of the blood–brain barrier in health and disease
Liebner, S., Dijkhuizen, R. M., Reiss, Y., Plate, K. H., Agalliu, D., & Constantin, G. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1815-1 · Cited by 872
Peripheral inflammation and blood–brain barrier disruption: effects and mechanisms
Huang, X., Hussain, B., & Chang, J. (2021) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13569 · Cited by 709
Cytokine networks in neuroinflammation
Becher, B., Spath, S., & Goverman, J. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2016.123 · Cited by 697
Self-citation
Metadata
- Authors
- Huppert, J., Closhen, D., Croxford, A., White, R., Kulig, P., Pietrowski, E., Bechmann, I., Becher, B., Luhmann, H. J., Waisman, A., & Kuhlmann, C. R. W.
- Affiliations
- Johannes Gutenberg University Mainz (DE)
- University of Zurich (CH)
- Leipzig University (DE)
- Corresponding author
- Waisman, Ari
- Kuhlmann, Christoph R. W.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2009-11-25
- Volume
- 24
- Issue
- 4
- Pages
- 1023-1034
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2071205488
- Semantic Scholar
- 28487cafa06774aea634538871f39aa337f374e1
- Cited by
- 529
- References
- 41
- Citations by year
- 2026: 29 · 2025: 41 · 2024: 43 · 2023: 40 · 2022: 43 · 2021: 44 · 2020: 21 · 2019: 21 · 2018: 31 · 2017: 28 · 2016: 32 · 2015: 31 · 2014: 27 · 2013: 35 · 2012: 15
- FWCI
- 13.42
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- Deutsche Forschungsgemeinschaft (SFB TR52/C2)
- Boehringer Ingelheim Stiftung
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
- Keywords
- IL-17A, blood-brain barrier disruption, Th17 cells, experimental autoimmune encephalomyelitis, reactive oxygen species, NADPH oxidase, xanthine oxidase, oxidative stress, myosin light chain phosphorylation, myosin light chain kinase, ML-7, occludin, tight junctions, endothelial contractility, monocyte adhesion, lymphocyte transendothelial migration, bEnd.3 endothelial cells
- MeSH terms
- Animals, Azepines, Blood-Brain Barrier, Cell Line, Transformed, Encephalomyelitis, Autoimmune, Experimental, Enzyme Inhibitors, T-Lymphocytes, Helper-Inducer, Membrane Proteins, Mice, Inbred BALB C, Myosin-Light-Chain Kinase, Naphthalenes, Xanthine Oxidase, Down-Regulation, Reactive Oxygen Species, Oxidative Stress, NADPH Oxidases, Interleukin-17, Endothelial Cells, Mice, Antibodies, Neutralizing, Occludin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.